No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Osso VR Delivers Stunning Level of Fidelity to Improve Global Surgical Outcomes

Editor: What To Know

  • For the first time, big-budget film and game studios are bringing their capabilities to medical VR to deliver solutions that are clinically accurate and emotionally compelling, preparing an entire generation to train in a new way while improving healthcare outcomes around the world.
  • Osso VR's technology is being used by more than 20 leading teaching hospitals and eight top medical device companies in 20 countries and has been shown to improve surgical performance by 230% in a peer-reviewed study in the Journal of Surgical Education.
  •   This group of oscar and emmy award winners bring an experience that is accurate, engaging, and educational making a significant impact on the adoption of our clinically validated platform,“ said Justin Barad MD, CEO and Co-Founder of Osso VR.

Osso VR, a validated Virtual Reality (VR) surgical training platform, is rolling out a new training experience in VR with an exceptional level of visual fidelity surrounding every aspect, from anatomical detail to the OR environment.

This novel immersive experience is a result of Osso VR’s unique creative team makeup, consisting of an Oscar-winning art director and the world’s largest medical illustration team with alums from Electronic Arts, Microsoft, and Apple. 

For the first time, big-budget film and game studios are bringing their capabilities to medical VR to deliver solutions that are clinically accurate and emotionally compelling, preparing an entire generation to train in a new way while improving healthcare outcomes around the world. 

Osso VR’s training platform is designed for surgeons, sales teams and other trainees to address complexities in learning new procedures and to use novel medical devices by providing realistic, haptic-enhanced interactions in an immersive training environment that is repeatable. 

“Osso VR’s team is lightning in a bottle.  A once in a lifetime team of leading engineers, artists and educators who have dedicated their careers to optimizing patient safety.  This group of oscar and emmy award winners bring an experience that is accurate, engaging, and educational making a significant impact on the adoption of our clinically validated platform,“ said Justin Barad MD, CEO and Co-Founder of Osso VR. “We’ve reached a level of detail in the anatomy, surgical tools, and the OR environment within the platform that was not previously possible.  This will improve our ability to accomplish our mission, improving patient outcomes, driving the adoption of high value technologies and democratizing access to surgical education globally.”

Jonathan Sabella, Art Director for Osso VR, has contributed to some of the most prominent content in entertainment, including films, games and VR. The central driving force in his work is his expertise in human and comparative anatomy, which he has used to bring to life memorable characters and performances for modern cinematic universes, including Marvel and Star Wars. 

“I am extremely proud to be a part of Osso. Supervising for Alejandro Iñárritu’s Oscar-winning VR film Carne y Arena opened my eyes to how virtual reality can impact the real world. When I saw what Justin and the team were doing I knew that it was something I wanted to contribute to.” said Sabella. “We are dedicated to bringing the virtual medical training experience to life, leaving no detail untouched. The colleagues I have the privilege of working with here are some of the most talented and professional I’ve had the opportunity to collaborate with. I’ve spent my career fascinated with anatomy and the chance to work directly with medical illustrators, engineers and leading doctors in the field to help save lives is something I cherish greatly.”

Osso VR’s technology is being used by more than 20 leading teaching hospitals and eight top medical device companies in 20 countries and has been shown to improve surgical performance by 230% in a peer-reviewed study in the Journal of Surgical Education. Focused on increasing access to hands-on training that improves patient outcomes and increases the adoption of higher value medical technology, Osso VR provides an immersive, repeatable environment to safely work up surgical learning curves. For more information visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy